Regorafenib Reverses Temozolomide-Induced CXCL12/CXCR4 Signaling and Triggers Apoptosis Mechanism in Glioblastoma

I‐Tsang Chiang(Central Taiwan University of Science and Technology), Fei‐Ting Hsu(China Medical University)
Neurotherapeutics
March 1, 2022
Cited by 27


Related Papers